Acute and Chronic Actions of a dry methanolic extract of Hypericum Perforatum and a Hyperforin-Rich Extract on Dopaminergic and Serotonergic Neurones in Rat Nucleus Accumbens

Dry hydroalcoholic extract of Hypericum perforatum L. is effective in the treatment of mild-to-moderate depression. Neither the mechanism of action nor the component or components of the extract responsible are known to date. In several in vitro and ex vivo models, the extract and hyperforin, one of its active components, cause changes similar to those of tricyclic antidepressants. Little is known about effects on a complex neuronal system relevant to antidepressant actions such as the mesolimbic system in the brain. In animal models of depression, the levels of dopamine were reduced in the nucleus accumbens, which is an important part of the mesolimbic system. These and other deficits were compensated by imipramine. We investigated the actions of the methanolic Hypericum extract LI 160 and a hyperforin-rich research extract in the shell region of the nucleus accumbens under in vivo conditions after acute administration, and after application repeated fourteen times. Both extracts induced an increase of dopamine (DA) and 5-hydroxytryptamine (5-HT) levels measured by in vivo microdialysis. The dose-response curve followed an inverse U-shape. Repeated application caused a rapid tolerance of DA but not of 5-HT neurones. Similar changes were observed after acute and repeated applications of imipramine. Several lines of evidence have suggested other active components in the Hypericum extract. The potency of hyperforin surpassed that of imipramine in the acute release of both DA and 5-HT by the nucleus accumbens. The effect of hyperforin correlated well with the inhibiting potency on high-affinity DA and 5-HT uptake. The missing effect of relatively high doses on DA and 5-HT levels as found in dose-response experiments may be explained by self-inhibition caused by the activation of autosomal receptors and by the inhibition by GABA. The inhibition of neuronal GABA transport occurs at somewhat higher concentrations of hyperforin. In conclusion, the findings demonstrate an imipramine-like effect of methanolic Hypericum extract LI 160 and of hyperforin on mesolimbic, dopaminergic and serotonergic neurones in acute and chronic experiments, which probably contributes to the antidepressant action of the medication. The methanolic Hypericum extract contains active compounds other than hyperforin.

References

• 1 Ainsworth K, Smith S E, Zetterstrom T S, Pei Q, Franklin M, Sparp T. Effect of antidepressant drugs on depamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.  Psychopharmacology. 1998;  140 470-477
• 2 Bel N, Artigas F. In vivo effects of the simulataneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies.  J Pharmacol Exp Ther. 1996;  278 1064-1072
• 3 Benloucif S, Keegan M J, Galloway P. Serotonin-facilitated dopamine release in vivo: pharmacological characterization.  J Pharmacol Exp Ther. 1993;  265 373-377
• 4 Biber A, Fischer H, Römer A, Chatterjee S S. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.  Pharmacopsychiat.. 1998;  31 (Suppl.) 6-43
• 5 Blier P, Montigny C, Tardif D. Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single cell studies in the rat.  Psychopharmacology. 1984;  84 242-249
• 6 Brodie M S, Bunney E B. Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vivo.  J Neurophysiol. 1996;  76 2077-2082
• 7 Butterweck V, Jürgenliemk G, Nahrstedt A, Winterhoff H. Flavonoids from hypericum perforatum show antidepressant activity in the forced swimming test.  Planta Med. 2000;  66 3-6
• 8 Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. Solubilized hypericin and pseudohypericin from hypericum perforatum exert antidepressant activity in the Forced Swimming Test.  Planta Med. 1998;  64 291-294
• 9 Campbell A D, McBride W J. Serotonin-3 receptor and ethanol stimulated dopamine release in the nucleus accumbens.  Pharmacol Biochem Behav. 1995;  51 835-842
• 10 Chatterjee S S, Bhattacharya S K, Wonnemann M, Singer A, Müller W E. Hyperforin as a possible antidepressant component of hypericum extracts.  Life Sci. 1998a;  63 499-510
• 11 Chatterjee S S, Nöldner M, Koch E, Erdelmeier C. Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.  Pharmacopsychiat. 1998;  31 (Suppl.) 7-15
• 12 Franklin M, Chi J D, Mannel M, Cowen P J. Acute effects of LI 160 (extract of Hypericum perforatum, St. John's wort) and two of its constituents on neuroendocrine responses in the rat.  Psychopharmacology. 2000;  14 360-363
• 13 Gambarana C, Masi F, Tagliamonte A, Scheggi S, Ghiglieri O, DeMontis M G. A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study.  J Neurochem. 1999;  72 2039-2046
• 14 Ghiglieri O, Gambarana C, Scheggi S, Tagliamonte A, Willner P, DeMontis M G. Palatable food induces an appetitive behavior in satiated rats which can be inhibited by chronic stress.  Behav Pharmacol. 1997;  8 619-628
• 15 Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking.  Brain Res Rev. 1999;  31 6-41
• 16 Ikemoto S, Kohl R R, McBride W J. GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats.  J Neurochem. 1997;  69 137-143
• 17 Karremann M, Westerink B HC, Moghaddam B. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum.  J Neurochem. 1996;  67 601-607
• 18 Legault M, Rompré P P, Wise R A. Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurones of the ventral tegmental area.  J Neurosci. 2000;  20 1635-1642
• 19 Markus M M, Nomikos G G, Svensson T H. Differential action of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens.  Eur Neuropharmacol. 1996;  6 29-38
• 20 Müller W E, Rolli M, Schäfer C, Hafner U. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.  Pharmacopsychiat. 1997;  30 (Suppl.) 102-117
• 21 Müller W E, Singer A, Wonnemann M, Hafner U, Rolli M, Schäfer C. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.  Pharmacopsychiat. 1998;  31 (Suppl.) 16-21
• 22 Nathan P J. The experimental and clinical pharmacology of St. John’s Wort (hypericum perforatum L).  Molec Psychiat. 1999;  4 333-338
• 23 Reynolds G P, Mason S L, Meldrum A, DeKeczer S, Parnes H, Eglen R M, Wong E HF. [³H]GR 113 808 binding to 5-HT₄ receptors in human neurodegenerative disorders.  Br J Pharmacol. 1994;  112 302P
• 24 Rommelspacher H. Modelle der Entstehung und Aufrechterhaltung süchtigen Verhaltens. In: Gastpar M, Mann K, Rommelspacher H (Hrsg.) Lehrbuch der Suchterkrankungen. Stuttgart, New York; Thieme Verlag 1999: 28-38
• 25 Rossetti Z L, Marcangione C, Wise R A. Increase of extracellular glutamate and expression of Fos-like immunoreactivity in the ventral tegmental area in response to electrical stimulation ot the prefrontal cortex.  J Neurochem. 1998;  70 1503-1511
• 26 Sällström Baum S, Hill R, Rommelspacher H. Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats.  Prog Neuropsychopharmacol Biol Psychiat. 1998;  22 1105-1120
• 27 Sällström Baum S, Hill R, Rommelspacher H. Harman-induced changes of extracellular concentrations of neurotransmitters in the nucleus accumbens of rats.  Eur J Pharmacol. 1996;  314  75-82
• 28 Sällström Baum S, Hill R, Rommelspacher H. Norharman-induced changes of extracellular concentrations of dopamine in the nucleus accumbens of rats.  Life Sci. 1995;  56 1715-1720
• 29 Singer A, Wonnemann M, Müller W E. Hyperforin, a major antidepressant constituent of St. John’s Wort, inhibits serotonin uptake by elevating free intracellular Na⁺.  J Pharmacol Exp Ther. 1999;  290 1363-1369
• 30 Teufel-Mayer R, Gleitz J. Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT_1A and 5-HT_2A receptors.  Pharmacopsychiat. 1997;  30 (Suppl.) 13-116
• 31 Waeber C, Hoyer D, Palacios J M. 5-Hydroxytryptamine receptors in the human brain: autoradiographic visualization using [³H]ICS 205 - 593.  Neurosci. 1989;  31 393-400
• 32 Wang T, O’Connor W T, Ungerstedt U, French E D. N-methyl-D-aspartic acid biphasically regulates the biochemical and electrophysiological response of A10 dopamine neurones in the ventral tegmental area: in vivo microdialysis and in vitro electrophysiological studies.  Brain Res. 1994;  666 255-262
• 33 Westerink B H, Enriko P, Feimann J, DeVries J B. The pharmacology of mesocortical dopamine neurones: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain.  J Pharmacol Exp Ther. 1998;  285 143-154
• 34 Williams W J, Mulrow C D, Chiquette E, Hitchcock N P, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults. Evidence report summary.  Ann Intern Med. 2000;  132 743-756
• 35 Winterhoff H, Butterweck V, Nahrstedt A, Gumbinger H G, Schulz V, Erping S, Boßhammer F, Wieligmann A. Pharmakologische Untersuchungen zur antidepressiven Wirkung von Hypericum perforatum L. In: Loew D, Rietbrock N (Hrsg.) Phytopharmaka in Forschung und klinischer Anwendung. Darmstadt; Steinkopf Verlag 1995: 39-56
• 36 Wonnemann M, Singer A, Müller W E. Inhibition of synaptosomal uptake of ³H-L-glutamate and ³H-GABA by hyperforin, a major constituent of St. John’s Wort. The role of amiloride-sensitive sodium conductive pathways.  Neuropsychopharmacol. 2000;  23 188-197
• 37 Ahmed S H, Koob G F. Transition from moderate to excessive drug intake: change in hedonia set point.  Science. 1998;  282 298-300